{"id":"W2339943063","doi":"10.1016/s1470-2045(16)00080-2","title":"Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":259,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Jewish General Hospital; Princess Margaret Cancer Centre","funders":"Ariad Pharmaceuticals","keywords":"Ponatinib; Medicine; Imatinib; Internal medicine; Myeloid leukemia; Imatinib mesylate; Oncology; Clinical trial; Clinical endpoint; Nilotinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001372379,0.0003038144,0.001052878,0.00008199015,0.0001735542,0.0000479604,0.001076991,0.0002468505,0.001046664],"category_scores_gemma":[0.001796795,0.0001694616,0.0001246898,0.0001175212,0.0002407655,0.000309152,0.0002343147,0.0002621197,0.0001616997],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003405822,"about_ca_system_score_gemma":0.002080399,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001090341,"about_ca_topic_score_gemma":0.0002716029,"domain_scores_codex":[0.9975819,0.0003292638,0.0006078525,0.0005504899,0.0002936587,0.0006368104],"domain_scores_gemma":[0.9948601,0.003451472,0.0003922049,0.0009277494,0.0001705409,0.0001980007],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7218275,0.00199425,0.00003442387,0.00003246378,0.0006702495,0.0001029528,0.0002604377,0.000002309815,0.007634851,0.001765154,0.0245733,0.2411021],"study_design_scores_gemma":[0.7431617,0.01262436,0.00005772259,0.00006655265,0.0002864519,0.00005257992,0.00004404226,0.0003264584,0.001004969,0.0002840867,0.2419284,0.0001627397],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9421853,0.0003561066,0.000600168,0.02501865,0.004449434,0.008364982,0.0002988756,0.0001885534,0.01853786],"genre_scores_gemma":[0.9525493,0.002395934,0.01047381,0.004170938,0.01580963,0.007238053,0.0007140893,0.0001755021,0.00647276],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2409394,"threshold_uncertainty_score":0.9998665,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1491709117621627,"score_gpt":0.447745619994161,"score_spread":0.2985747082319983,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}